Andrew Synn is a Respiratory physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 68 publications with 437 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
75.8%Corticosteroid32.3%Symbicort27%Trelegy Ellipta23%Fluticasone Propionate19%Arnuity Ellipta18%Dulera13%Part D<11 patientsbeta2-Adrenergic Agonist30.8%Albuterol Sulfate Hfa81%Ventolin Hfa19%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
15.4%Corticosteroid15.4%Prednisone100%Part D≥13 patientsAnti-infectives
8.8%Short-acting sulfonamides8.8%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- Pulmonary Vascular Pruning on Computed Tomography and Interstitial Lung Disease Outcomes
Beth Israel Deaconess Medical Center
FY2026$191,484K23HL164976 - Pulmonary Vascular Pruning on Computed Tomography and Interstitial Lung Disease Outcomes
Beth Israel Deaconess Medical Center
FY2025$191,484K23HL164976 - Pulmonary Vascular Pruning on Computed Tomography and Interstitial Lung Disease Outcomes
Beth Israel Deaconess Medical Center
FY2024$191,186K23HL164976
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
Fernando Martinez, MD
University of Massachusetts Chan Medical School
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”